MP-13, a novel chimeric peptide of morphiceptin and pepcan-9, produces potent antinociception with limited side effects-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

MP-13, a novel chimeric peptide of morphiceptin and pepcan-9, produces potent antinociception with limited side effects

Published:2024-10 Issue: Volume:107 Page:102440
ISSN:0143-4179
Container-title:Neuropeptides
language:en
Short-container-title:Neuropeptides

Author:

Mei Chenxi,Zhang Jing,Niu Zhanyu,Simon Jerine Peter,Yang Tong,Huang Mingmin,Zhang Zhonghua,Zhou Lanxia,Dong Shouliang

Funder

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Natural Science Foundation of Gansu Province

Publisher

Elsevier BV

Reference59 articles.

1. Novel virtual screening approach for the discovery of human tyrosinase inhibitors;Ai;PLoS One,2014

2. Opioid tolerance in periaqueductal gray neurons isolated from mice chronically treated with morphine;Bagley;Br. J. Pharmacol.,2005

3. Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors*;Bauer;J. Biol. Chem.,2012

4. Molecular docking and dynamics studies to explore effective inhibitory peptides against the spike receptor binding domain of SARS-CoV-2;Biswas,2022

5. Assessment and analysis of mechanical allodynia-like behavior induced by spared nerve injury (SNI) in the mouse;Bourquin;Pain,2006

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP